Blood Donation and Victoza (Victoza/Liraglutide): Eligibility & Guidelines
Donating Blood While Taking Liraglutide (Victoza®)
Liraglutide is a GLP‑1 receptor agonist for type 2 diabetes. The FDA does not prohibit blood donation solely based on this medication. Eligibility hinges on the donor’s overall health and glycemic control.
General Diabetes Donation Criteria (Red Cross / AABB)
- Diabetes well‑controlled (HbA1c <8% preferred, no recent DKA/HHS).
- No diabetic complications requiring vascular surgery, amputation, or active ulceration.
- Not on insulin? No deferral. On insulin? Acceptable if stable.
- No bovine insulin exposure since 1980 (vCJD risk).
Victoza‑Specific Considerations
- Liraglutide is not a blood‑borne pathogen risk.
- Some centers may ask about recent dose changes or hypoglycemia episodes.
- Injection‑site reactions (bruising) should be healed before phlebotomy.
Steps Before Donating
- Call the donation center (Red Cross: 1‑800‑RED‑CROSS) and disclose medication.
- Bring medication list; know your last HbA1c.
- Hydrate well; eat a balanced meal before appointment.
- If deferred, ask for specific reason and re‑eligibility timeline.
Most stable type 2 diabetics on GLP‑1 agonists donate successfully.
Blood Disorders - Related Articles
- Interpreting Blood Test Results: CBC, Chemistry, Lipids, and Clinical Context
- Iron Deficiency Anemia: Global Prevalence & Risk Factors
- Normal Menstrual Blood Loss: Average Volume and When to Seek Help
- PTSD, Major Depression, and Dysthymia After Assault: Comorbidity and Treatment
- Blood Type Matching in Transplants: Why Compatibility Is Critical
- Repliva Side Effects: Common & Serious Reactions
- Iron Deficiency Anemia: Global Burden, Pathophysiology, and WHO Statistics
